Literature DB >> 2390628

Desensitisation today.

.   

Abstract

Mesh：

Year:  1990        PMID： 2390628      PMCID： PMC1663463     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Comparison of the efficacy and side effects of aqueous steroid nasal spray (budesonide) and allergen-injection therapy (Pollinex-R) in the treatment of seasonal allergic rhinoconjunctivitis.

Authors:  E F Juniper; P A Kline; E H Ramsdale; F E Hargreave
Journal:  J Allergy Clin Immunol       Date:  1990-03       Impact factor: 10.793

Review 2.  Desensitisation today.

Authors:  N Eiser
Journal:  BMJ       Date:  1990-06-02

Review 3.  Current status of allergen immunotherapy. Shortened version of a World Health Organisation/International Union of Immunological Societies Working Group Report.

Authors: 
Journal:  Lancet       Date:  1989-02-04       Impact factor: 79.321

4.  Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract.

Authors:  M Horst; A Hejjaoui; V Horst; F B Michel; J Bousquet
Journal:  J Allergy Clin Immunol       Date:  1990-02       Impact factor: 10.793

5.  A double-blind, placebo-controlled trial of polymerized whole ragweed for immunotherapy of ragweed allergy.

Authors:  L C Grammer; C R Zeiss; I M Suszko; M A Shaughnessy; R Patterson
Journal:  J Allergy Clin Immunol       Date:  1982-06       Impact factor: 10.793

6.  Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. III. Efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma.

Authors:  J Bousquet; H J Maasch; A Hejjaoui; W Skassa-Brociek; R Wahl; H Dhivert; F B Michel
Journal:  J Allergy Clin Immunol       Date:  1989-10       Impact factor: 10.793

7.  Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy.

Authors:  J Bousquet; A Hejjaoui; A M Clauzel; B Guérin; H Dhivert; W Skassa-Brociek; F B Michel
Journal:  J Allergy Clin Immunol       Date:  1988-12       Impact factor: 10.793
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.